Grail (GRAL) Scheduled to Post Quarterly Earnings on Tuesday

Grail (NASDAQ:GRAL) will announce its earnings results after the market closes on Tuesday, November 12th. Individual that wish to register for the company’s earnings conference call can do so using this link.

Grail (NASDAQ:GRAL) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($5.30) EPS for the quarter. The business had revenue of $31.97 million during the quarter.

Grail Price Performance

Shares of GRAL traded up $0.26 during trading hours on Tuesday, reaching $14.24. The company’s stock had a trading volume of 107,845 shares, compared to its average volume of 1,120,683. The firm has a 50 day moving average of $13.65. Grail has a 1-year low of $12.33 and a 1-year high of $23.36.

Analyst Ratings Changes

Separately, Guggenheim initiated coverage on shares of Grail in a research note on Thursday, October 17th. They issued a “neutral” rating on the stock.

Insider Buying and Selling

In other news, major shareholder Chun R. Ding bought 7,629 shares of the stock in a transaction on Tuesday, October 1st. The shares were purchased at an average price of $13.52 per share, for a total transaction of $103,144.08. Following the completion of the purchase, the insider now directly owns 3,503,655 shares of the company’s stock, valued at $47,369,415.60. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, major shareholder Chun R. Ding purchased 7,629 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was bought at an average cost of $13.52 per share, with a total value of $103,144.08. Following the purchase, the insider now directly owns 3,503,655 shares of the company’s stock, valued at approximately $47,369,415.60. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Chun R. Ding purchased 16,200 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $12.92 per share, with a total value of $209,304.00. Following the purchase, the insider now owns 3,644,855 shares in the company, valued at $47,091,526.60. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 58,829 shares of company stock worth $757,298.

Grail Company Profile

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.